Page last updated: 2024-08-23

daunorubicin and dabrafenib

daunorubicin has been researched along with dabrafenib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Ahmed, F; Ceckova, M; Hofman, J; Sorf, A; Vagiannis, D	1

Other Studies

1 other study(ies) available for daunorubicin and dabrafenib

Article	Year
Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy. Toxicology and applied pharmacology, 2022, 01-01, Volume: 434 Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Daunorubicin; Dogs; Drug Therapy, Combination; Gene Expression Regulation; Humans; Imidazoles; Mitoxantrone; Oximes; RNA, Messenger	2022

Article

Year

Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy.

Toxicology and applied pharmacology, 2022, 01-01, Volume: 434

Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; Cell Line, Tumor; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Daunorubicin; Dogs; Drug Therapy, Combination; Gene Expression Regulation; Humans; Imidazoles; Mitoxantrone; Oximes; RNA, Messenger

2022